Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|November 9, 2010
Angiosarcoma: state of the art and perspectivesNicolas Penel, Sandrine Marréaud, Yves-Marie Robin, et al.
Clinical Sarcoma Research|September 18, 2020
Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database studyArie Jan Verschoor, Saskia Litière, Sandrine Marréaud, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)Pierre Fumoleau, Kevin M Koch, Etienne Brain, et al.
Breast (Edinburgh, Scotland)|May 31, 2022
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progressionHans Wildiers, Thomas Meyskens, Sandrine Marréaud, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2016
Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entityMyrella Vlenterie, Saskia Litière, Elisa Rizzo, et al.
Sarcoma|April 11, 2022
Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) DatabaseGeorgios Kantidakis, Saskia Litière, Hans Gelderblom, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomasGeorgios Kantidakis, Saskia Litière, Anouk Neven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2017
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trialPatrick Schöffski, Agnieszka Wozniak, Bernard Escudier, et al.
Pageof 2